Background
Tissue-engineered vascular grafts (TEVGs) offer potential to overcome
limitations of current approaches for reconstruction in congenital heart
disease by providing biodegradable scaffolds on which autologous cells
proliferate and provide physiologic functionality. However, current TEVGs do
not address the diverse anatomic requirements of individual patients. This
study explores the feasibility of creating patient-specific TEVGs by
combining 3-dimensional (3D) printing and electrospinning technology.
Methods
An electrospinning mandrel was 3D-printed after computer-aided design
based on preoperative imaging of the ovine thoracic inferior vena cava
(IVC). TEVG scaffolds were then electrospun around the 3D-printed mandrel.
Six patient-specific TEVGs were implanted as cell-free IVC interposition
conduits in a sheep model and explanted after 6 months for histologic,
biochemical, and biomechanical evaluation.
Results
All sheep survived without complications, and all grafts were patent
without aneurysm formation or ectopic calcification. Serial angiography
revealed significant decreases in TEVG pressure gradients between 3 and 6
months as the grafts remodeled. At explant, the nanofiber scaffold was
nearly completely resorbed and the TEVG showed similar mechanical properties
to that of native IVC. Histological analysis demonstrated an organized
smooth muscle cell layer, extracellular matrix deposition, and
endothelialization. No significant difference in elastin and collagen
content between the TEVG and native IVC was identified. There was a
significant positive correlation between wall thickness and
CD68+ macrophage infiltration into the TEVG.
Conclusions
Creation of patient-specific nanofiber TEVGs by combining
electrospinning and 3D printing is a feasible technology as future clinical
option. Further preclinical studies involving more complex anatomical shapes
are warranted.